One of the reasons why precision oncology is so effective is because it enables us to take advantage of the most up-to-date scientific discoveries in cancer research and drug development. The use of a new class of drugs – called immune checkpoint inhibitors – is a great example of this. These drugs are known to have excellent results for cancer patients with certain genetic mutations (in this case, the PD-1 expression) in their tumours.
At CTOAM, our Cancer Care Research and Advocacy Specialists ensure that you get access to MMR and MSI testing, immediately. This allows us to identify the best treatment protocol for you, as soon as possible.
"Checkpoint inhibitors are coming into widespread use and are being tried in advanced types of cancer for which standard chemotherapy offers little hope."
So getting these tests done will help us to determine whether this new class of drugs (immune checkpoint inhibitors) is likely to work for you. And the test results give us the documentation needed to get you access to the drugs through your oncologist or a clinical trial – as quickly as possible. If the tests show that immunotherapy will benefit you, then the sooner you begin treatment the sooner you can start feeling better.
And while these new drugs currently aren’t being offered by standard care, experts in the field agree that, with time, immunotherapy will absolutely become the standard in cancer care. In the meantime, precision oncology services like CTOAM are here to ensure that you have access to these life-saving drugs – and the tests to prove you need them – now.
It’s also important to note that new immunotherapy drugs are being developed every day. When you become a CTOAM client, you will receive all updates about new developments in drugs that might benefit you. This is the promise of precision oncology, and the commitment that CTOAM makes to our clients.
If you or a loved one has received a cancer diagnosis and would like to know whether immunotherapy might benefit them, please email or call us today. Our Cancer Care Research and Advocacy Specialists will be happy to provide all the information you need.
Register for a Precision Second Opinion to discuss your particular situation in more detail. Time is of the essence with cancer – and getting more information can only help, when it comes to your health.
Get the latest advancements in cancer care delivered straight to your inbox each month!